This migration defect was present in neutrophils from MDS patients that did not have a mutation in spliceosome genes and in neutrophils from patients that had mutations in either the U2AF1 or SF3B1 spliceosome genes (Fig. 6). Here, SF3B1 is linked to myelodysplastic syndrome.